Condition

Anal Margin Squamous Cell Carcinoma

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions18

Lead sponsors shown1

Clinical trials

1 shown

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerNCT04929028 · 2022-08-09

ACTIVE_NOT_RECRUITING

Common interventions

AnoscopyPROCEDURE1Biospecimen CollectionPROCEDURE1CapecitabineDRUG1ColonoscopyPROCEDURE1Computed TomographyPROCEDURE1Digital Rectal ExaminationPROCEDURE1Echocardiography TestPROCEDURE1Fludeoxyglucose F-18OTHER1FluorouracilDRUG1Intensity-Modulated Radiation TherapyRADIATION1Lymph Node BiopsyPROCEDURE1Magnetic Resonance ImagingPROCEDURE1MitomycinDRUG1NivolumabBIOLOGICAL1Positron Emission TomographyPROCEDURE1ProctoscopyPROCEDURE1Questionnaire AdministrationOTHER1SigmoidoscopyPROCEDURE1

Leading sponsors

National Cancer Institute (NCI)1

Trial status mix

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.